# ANGIOPREDICT. ICORG 12-16, V3

> **NCT01822444** · — · COMPLETED · sponsor: **Cancer Trials Ireland** · enrollment: 76 (actual)

## Conditions studied

- Advanced Colorectal Cancer

## Interventions

- **OTHER:** Biomarker analysis

## Key facts

- **NCT ID:** NCT01822444
- **Lead sponsor:** Cancer Trials Ireland
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01822444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01822444, "ANGIOPREDICT. ICORG 12-16, V3". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01822444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*